Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04939506 · ClinicalTrials.gov registry record · NA
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana
A NA study, sponsored by Xavier University of Louisiana..
- Completed
- Registry status
- NA
- Development phase
- 379
- Enrollment target
NCT04939506 is a NA study that has completed, run by Xavier University of Louisiana.. The registered enrollment target is 379 participants.
The verdict
NCT04939506, a NA study, has completed, sponsored by Xavier University of Louisiana..
- COMPLETED
- Registry status
- NA
- Development phase
- 379 participants
- Enrollment target
Study Summary
This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID testing, from pharmacies, urgent cares and clinics using a rapid vaccine education model delivered at the point of care.
Interventions
- BEHAVIORAL COVID-19 Vaccine Education at the Point of COVID-19 Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04939506
The ClinicalTrials.gov registry entry for NCT04939506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 379 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xavier University of Louisiana., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 Vaccine Education at the Point of COVID-19 Testing is the first listed.
NCT04939506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04939506 about?
NCT04939506 is a clinical study titled "COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in SE Louisiana". This project is a 2-year study to investigate vaccine hesitancy and vaccine completion among vulnerable communities in the Southeastern Louisiana region. This study will be used to track COVID-19 vaccine completion among patients who seek testing, either as in-person or purchasing at home COVID test...
What is the current status of trial NCT04939506?
This trial is currently completed. It is a NA study. The enrollment target is 379 participants. The study started on 2022-09-01. Estimated completion is 2024-01-25.
What interventions are being tested in trial NCT04939506?
The interventions under investigation include: COVID-19 Vaccine Education at the Point of COVID-19 Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04939506?
This trial is sponsored by Xavier University of Louisiana., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.